BIO 2026

Enzene Launches Nex Partnership Initiative at BIO

BIO 2026

SK pharmteco Launches SKyvec Platform for Multimodal Viral Vectors

SKyvec unites three core modalities into a single offering affording flexibility for therapeutics developers.

BIO 2026

Shilpa Biologicals Launches PartnerPower for Real-Time CDMO Transparency

Platform provides real-time visibility on process development and GMP manufacturing.

BIO 2026

HIPRA Biotech Services Strengthens Agile Biologics Manufacturing Strategy

Redesigns development and manufacturing approach to support increasingly complex and fast-moving market needs.

BIO 2026

Johnson & Johnson to Acquire Firefly Bio for $1B

Firefly brings Firelink degrader antibody conjugate platform approach designed to deliver a highly selective protein degrader to tumor cells, while avoiding healthy cells.